These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 17204315)
1. Successful sublingual immunotherapy with birch pollen has limited effects on concomitant food allergy to apple and the immune response to the Bet v 1 homolog Mal d 1. Kinaciyan T; Jahn-Schmid B; Radakovics A; Zwölfer B; Schreiber C; Francis JN; Ebner C; Bohle B J Allergy Clin Immunol; 2007 Apr; 119(4):937-43. PubMed ID: 17204315 [TBL] [Abstract][Full Text] [Related]
2. Birch-apple syndrome treated with birch pollen immunotherapy. Mauro M; Russello M; Incorvaia C; Gazzola G; Frati F; Moingeon P; Passalacqua G Int Arch Allergy Immunol; 2011; 156(4):416-22. PubMed ID: 21832831 [TBL] [Abstract][Full Text] [Related]
3. Continuous apple consumption induces oral tolerance in birch-pollen-associated apple allergy. Kopac P; Rudin M; Gentinetta T; Gerber R; Pichler Ch; Hausmann O; Schnyder B; Pichler WJ Allergy; 2012 Feb; 67(2):280-5. PubMed ID: 22070352 [TBL] [Abstract][Full Text] [Related]
4. Bet v 1142-156 is the dominant T-cell epitope of the major birch pollen allergen and important for cross-reactivity with Bet v 1-related food allergens. Jahn-Schmid B; Radakovics A; Lüttkopf D; Scheurer S; Vieths S; Ebner C; Bohle B J Allergy Clin Immunol; 2005 Jul; 116(1):213-9. PubMed ID: 15990797 [TBL] [Abstract][Full Text] [Related]
5. Allergen immunotherapy for birch-apple syndrome: what do we know? Incorvaia C; Ridolo E; Mauro M; Russello M; Pastorello E Immunotherapy; 2017 Nov; 9(15):1271-1278. PubMed ID: 29130794 [TBL] [Abstract][Full Text] [Related]
6. Identification of B-cell epitopes of Bet v 1 involved in cross-reactivity with food allergens. Klinglmayr E; Hauser M; Zimmermann F; Dissertori O; Lackner P; Wopfner N; Ferreira F; Wallner M Allergy; 2009 Apr; 64(4):647-51. PubMed ID: 19154550 [TBL] [Abstract][Full Text] [Related]
7. Immunoblotting in the diagnosis of cross-reactivity in children allergic to birch. Cudowska B; Kaczmarski M; Restani P Rocz Akad Med Bialymst; 2005; 50():268-73. PubMed ID: 16358981 [TBL] [Abstract][Full Text] [Related]
8. Kinetics, cross-reactivity, and specificity of Bet v 1-specific IgG4 antibodies induced by immunotherapy with birch pollen. Subbarayal B; Schiller D; Möbs C; de Jong NW; Ebner C; Reider N; Bartel D; Lidholm J; Pfützner W; Gerth van Wijk R; Vieths S; Bohle B Allergy; 2013 Nov; 68(11):1377-86. PubMed ID: 24053565 [TBL] [Abstract][Full Text] [Related]
9. Oral exposure to Mal d 1 affects the immune response in patients with birch pollen allergy. Geroldinger-Simic M; Kinaciyan T; Nagl B; Baumgartner-Durchschlag U; Huber H; Ebner C; Lidholm J; Bartel D; Vieths S; Jahn-Schmid B; Bohle B J Allergy Clin Immunol; 2013 Jan; 131(1):94-102. PubMed ID: 22921871 [TBL] [Abstract][Full Text] [Related]
10. Food allergy to apple and specific immunotherapy with birch pollen. Hansen KS; Khinchi MS; Skov PS; Bindslev-Jensen C; Poulsen LK; Malling HJ Mol Nutr Food Res; 2004 Nov; 48(6):441-8. PubMed ID: 15508179 [TBL] [Abstract][Full Text] [Related]
11. Sensitization profiles in birch pollen-allergic patients with and without oral allergy syndrome to apple: lessons from multiplexed component-resolved allergy diagnosis. Ebo DG; Bridts CH; Verweij MM; De Knop KJ; Hagendorens MM; De Clerck LS; Stevens WJ Clin Exp Allergy; 2010 Feb; 40(2):339-47. PubMed ID: 19709127 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of 4 months of sublingual immunotherapy with recombinant Mal d 1 and Bet v 1 in patients with birch pollen-related apple allergy. Kinaciyan T; Nagl B; Faustmann S; Frommlet F; Kopp S; Wolkersdorfer M; Wöhrl S; Bastl K; Huber H; Berger U; Bohle B J Allergy Clin Immunol; 2018 Mar; 141(3):1002-1008. PubMed ID: 28870463 [TBL] [Abstract][Full Text] [Related]
13. Soybean allergy in patients allergic to birch pollen: clinical investigation and molecular characterization of allergens. Mittag D; Vieths S; Vogel L; Becker WM; Rihs HP; Helbling A; Wüthrich B; Ballmer-Weber BK J Allergy Clin Immunol; 2004 Jan; 113(1):148-54. PubMed ID: 14713921 [TBL] [Abstract][Full Text] [Related]
14. Apple desensitization in two patients with PR-10 proteins allergy. Nucera E; Aruanno A; Lombardo C; Patriarca G; Schiavino D Allergy; 2010 Aug; 65(8):1060-1. PubMed ID: 19958318 [No Abstract] [Full Text] [Related]
15. Allergy to jackfruit: a novel example of Bet v 1-related food allergy. Bolhaar ST; Ree R; Bruijnzeel-Koomen CA; Knulst AC; Zuidmeer L Allergy; 2004 Nov; 59(11):1187-92. PubMed ID: 15461600 [TBL] [Abstract][Full Text] [Related]
16. Recombinant Mal d 1 facilitates sublingual challenge tests of birch pollen-allergic patients with apple allergy. Kinaciyan T; Nagl B; Faustmann S; Kopp S; Wolkersdorfer M; Bohle B Allergy; 2016 Feb; 71(2):272-4. PubMed ID: 26443126 [TBL] [Abstract][Full Text] [Related]
17. High correlation of specific IgE sensitization between birch pollen, soy and apple allergens indicates pollen-food allergy syndrome among birch pollen allergic patients in northern China. Hao GD; Zheng YW; Wang ZX; Kong XA; Song ZJ; Lai XX; Spangfort MD J Zhejiang Univ Sci B; 2016 May; 17(5):399-404. PubMed ID: 27143268 [TBL] [Abstract][Full Text] [Related]
18. Effect of tree pollen specific, subcutaneous immunotherapy on the oral allergy syndrome to apple and hazelnut. Bucher X; Pichler WJ; Dahinden CA; Helbling A Allergy; 2004 Dec; 59(12):1272-6. PubMed ID: 15507095 [TBL] [Abstract][Full Text] [Related]
19. The Effect of Birch Pollen Immunotherapy on Apple and rMal d 1 Challenges in Adults with Apple Allergy. van der Valk JPM; Nagl B; van Wljk RG; Bohle B; de Jong NW Nutrients; 2020 Feb; 12(2):. PubMed ID: 32085633 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Bolhaar ST; Tiemessen MM; Zuidmeer L; van Leeuwen A; Hoffmann-Sommergruber K; Bruijnzeel-Koomen CA; Taams LS; Knol EF; van Hoffen E; van Ree R; Knulst AC Clin Exp Allergy; 2004 May; 34(5):761-9. PubMed ID: 15144469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]